Should Good-Looking Embryos Undergo Preimplantation Genetic Testing?
A 40-year-old woman named Ha from Ho Chi Minh City is undergoing in vitro fertilization (IVF) and has produced three day-5 embryos that appear morphologically excellent. She is seeking advice on whether to proceed with preimplantation genetic testing (PGT) for these embryos. Ha hopes that PGT will increase her chances of a successful pregnancy. The question arises from her concern about whether embryos that look good on the surface require further screening before implantation. This decision point is crucial for patients undergoing IVF, especially those in their forties where reproductive success rates can be lower.
The patient's query highlights a common dilemma in assisted reproductive technology: the balance between morphological assessment and genetic screening of embryos. While visually appealing embryos suggest good development, genetic abnormalities can still exist and lead to implantation failure or miscarriage. PGT aims to identify chromosomal aneuploidies and specific genetic disorders, potentially improving implantation rates and reducing the time to pregnancy. However, PGT involves additional costs, time, and the risk of embryo damage or misdiagnosis. For a 40-year-old patient, the decision involves weighing the increased risk of aneuploidy with age against the benefits and risks of PGT. This choice is influenced by individual medical history, financial considerations, and the specific goals of fertility treatment, prompting a personalized risk-benefit analysis.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.